福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRTX 福泰制药

盘前交易 04-03 06:35:08 EDT

483.49

-1.25

-0.26%

盘前475.00

-8.49-1.76%

06:18 EDT

最高487.93	最低480.42	成交量98.84万
今开481.64	昨收484.74	日振幅1.55%
总市值1,242亿	流通市值1,238亿	总股本2.57亿
成交额4.79亿	换手率0.39%	流通股本2.56亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRTX","market":"US","secType":"STK","nameCN":"福泰制药","latestPrice":483.49,"timestamp":1743624000000,"preClose":484.74,"halted":0,"volume":988397,"hourTrading":{"tag":"盘前","latestPrice":475,"preClose":483.49,"latestTime":"06:18 EDT","volume":2,"amount":946.6,"timestamp":1743675493697},"delay":0,"floatShares":255992485,"shares":256789869,"eps":-2.08,"marketStatus":"盘前交易","change":-1.25,"latestTime":"04-03 06:35:08 EDT","open":481.64,"high":487.925,"low":480.415,"amount":478536202.99448,"amplitude":0.015493,"askPrice":476.31,"askSize":2,"bidPrice":475,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-2.08,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1743687000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":483.49,"preHourTrading":{"tag":"盘前","latestPrice":475,"preClose":483.49,"latestTime":"06:18 EDT","volume":2,"amount":946.6,"timestamp":1743675493697},"postHourTrading":{"tag":"盘后","latestPrice":482,"preClose":483.49,"latestTime":"19:56 EDT","volume":70336,"amount":33977541.9944,"timestamp":1743638201425},"volumeRatio":0.6746626676192792,"impliedVol":0.3393,"impliedVolPercentile":0.76},"requestUrl":"/m/hq/s/VRTX/wiki","defaultTab":"wiki","newsList":[{"id":"2524471100","title":"福泰制药4月2日成交额为4.78亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524471100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2524471100?lang=zh_cn&edition=full","pubTime":"2025-04-03 10:54","pubTimestamp":1743648886,"startTime":"0","endTime":"0","summary":"美东时间2025年4月2日，福泰制药成交额为4.78亿美元，成交额较昨日减少21.09%，当日成交量为98.84万股。福泰制药于2025年4月2日跌0.26%，报483.49美元，该股过去5个交易日跌3.36%，年初至今涨20.06%，过去60日涨18.76%。此外，福泰正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂，以及APOL1介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403105447a44c0fdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0079474960.USD","LU1069344957.HKD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4532","IE00B19Z3581.USD","LU0256863811.USD","BK4585","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU2362541273.HKD","LU0234570918.USD","LU2362540622.SGD","IE00B2B36J28.USD","LU2237438978.USD","LU1093756325.SGD","BK4588","IE00B19Z3B42.SGD","BK4533","LU0889565916.HKD","LU2236285917.USD","LU0058720904.USD","IE0002270589.USD","LU1585245621.USD","LU0289739699.SGD","IE00B19Z9P08.USD","BK4139","LU0823416689.USD","LU1035775433.USD","LU1430594728.SGD","LU2462157665.USD","LU1093756168.USD","VRTX","IE00B4R5TH58.HKD","IE00B19Z9Z06.USD","BK4567","IE00BFTCPJ56.SGD","LU2362541513.USD","LU2456880835.USD","IE00BJT1NW94.SGD","LU2417539215.USD","IE0009355771.USD","LU2324357040.USD","LU0061475181.USD","IE0002141913.USD","LU0417517546.SGD"],"gpt_icon":0},{"id":"2524497001","title":"加拿大皇家银行：维持Vertex Pharmaceuticals评级，由与大盘持平调整至与大盘持平评级, 目标价由408.00美元调整至420.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2524497001","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2524497001?lang=zh_cn&edition=full","pubTime":"2025-04-02 00:02","pubTimestamp":1743523361,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：维持Vertex Pharmaceuticals(VRTX.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由408.00美元调整至420.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040200073694c8d575&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERX","VRTX"],"gpt_icon":0},{"id":"2524133093","title":"福泰制药3月31日成交额为10.79亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524133093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2524133093?lang=zh_cn&edition=full","pubTime":"2025-04-01 10:54","pubTimestamp":1743476057,"startTime":"0","endTime":"0","summary":"美东时间2025年3月31日，福泰制药成交额为10.79亿美元，成交额较昨日增加70.27%，当日成交量为223.19万股。福泰制药于2025年3月31日跌1.6%，报484.82美元，该股过去5个交易日跌5.26%，年初至今涨20.39%，过去60日涨20.39%。此外，福泰正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂，以及APOL1介导的肾脏疾病的小分子抑制剂。福泰还在研究细胞疗法，以为1 型糖尿病提供潜在的功能性治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401105424a6ab5195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234570918.USD","IE00B19Z3581.USD","IE0009355771.USD","LU0256863811.USD","LU2417539215.USD","IE00B2B36J28.USD","LU2362541513.USD","IE00BJT1NW94.SGD","IE0002270589.USD","LU0058720904.USD","LU2236285917.USD","LU1585245621.USD","IE00B19Z9P08.USD","LU0823416689.USD","LU2237438978.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","BK4532","IE00B19Z3B42.SGD","IE00BZ9MQY76.HKD","LU1093756168.USD","BK4567","IE0002141913.USD","LU0079474960.USD","LU0320765992.SGD","LU0289739699.SGD","IE00B19Z9Z06.USD","LU0061475181.USD","LU1093756325.SGD","VRTX","LU0417517546.SGD","IE00B894F039.SGD","LU0109394709.USD","BK4533","BK4585","LU1035775433.USD","LU2362540622.SGD","LU2456880835.USD","BK4588","LU2462157665.USD","LU2362541273.HKD","IE00BJJMRZ35.SGD","LU1430594728.SGD","IE00B4R5TH58.HKD","LU2324357040.USD","LU1069344957.HKD","BK4139"],"gpt_icon":0},{"id":"2523652239","title":"福泰制药3月28日成交额为6.33亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2523652239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2523652239?lang=zh_cn&edition=full","pubTime":"2025-03-29 10:48","pubTimestamp":1743216498,"startTime":"0","endTime":"0","summary":"美东时间2025年3月28日，福泰制药成交额为6.33亿美元，成交额较昨日增加2.07%，当日成交量为128.10万股。福泰制药于2025年3月28日跌1.96%，报492.69美元，该股过去5个交易日跌2.09%，年初至今涨22.35%，过去60日涨23.37%。其主要药物是Kalydeco、Orkambi、Symdeko和用于治疗囊性纤维化的Trikafta/Kaftrio，其中福泰疗法仍然是全球治疗标准。此外，福泰正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂，以及APOL1介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250329104823a44610e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0079474960.USD","LU1069344957.HKD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4532","IE00B19Z3581.USD","LU0256863811.USD","BK4585","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU2362541273.HKD","LU0234570918.USD","LU2362540622.SGD","IE00B2B36J28.USD","LU2237438978.USD","LU1093756325.SGD","BK4588","IE00B19Z3B42.SGD","BK4533","LU0889565916.HKD","LU2236285917.USD","LU0058720904.USD","IE0002270589.USD","LU1585245621.USD","LU0289739699.SGD","IE00B19Z9P08.USD","BK4139","LU0823416689.USD","LU1035775433.USD","LU1430594728.SGD","LU2462157665.USD","LU1093756168.USD","VRTX","IE00B4R5TH58.HKD","IE00B19Z9Z06.USD","BK4567","IE00BFTCPJ56.SGD","LU2362541513.USD","LU2456880835.USD","IE00BJT1NW94.SGD","LU2417539215.USD","IE0009355771.USD","LU2324357040.USD","LU0061475181.USD","IE0002141913.USD","LU0417517546.SGD"],"gpt_icon":0},{"id":"2522439464","title":"福泰制药3月26日成交额为6.66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522439464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2522439464?lang=zh_cn&edition=full","pubTime":"2025-03-27 11:20","pubTimestamp":1743045605,"startTime":"0","endTime":"0","summary":"美东时间2025年3月26日，福泰制药成交额为6.66亿美元，成交额较昨日增加30.06%，当日成交量为132.88万股。福泰制药于2025年3月26日跌1.72%，报500.28美元，该股过去5个交易日跌2.39%，年初至今涨24.23%，过去60日涨21.83%。其主要药物是Kalydeco、Orkambi、Symdeko和用于治疗囊性纤维化的Trikafta/Kaftrio，其中福泰疗法仍然是全球治疗标准。此外，福泰正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂，以及APOL1介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327112010a6a5887a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2362540622.SGD","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU1585245621.USD","LU2456880835.USD","LU0079474960.USD","LU2417539215.USD","LU0320765992.SGD","BK4533","IE00BJJMRZ35.SGD","LU2362541513.USD","LU0417517546.SGD","BK4588","LU0889565916.HKD","LU2362541273.HKD","BK4567","LU0256863811.USD","BK4585","LU1069344957.HKD","LU0823416689.USD","IE0002141913.USD","IE00BZ9MQY76.HKD","LU1093756168.USD","LU1430594728.SGD","BK4532","LU2237438978.USD","IE00B2B36J28.USD","LU0061475181.USD","LU0058720904.USD","LU2324357040.USD","LU0109394709.USD","LU0234570918.USD","IE00B19Z3B42.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU2462157665.USD","IE0002270589.USD","IE00B19Z3581.USD","LU1093756325.SGD","LU1035775433.USD","LU2236285917.USD","LU0289739699.SGD","VRTX","BK4139","IE00B894F039.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2522840542","title":"谷歌继续上新：推理模型2.5 Pro发布，多项测试击败OpenAI和Grok","url":"https://stock-news.laohu8.com/highlight/detail?id=2522840542","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2522840542?lang=zh_cn&edition=full","pubTime":"2025-03-26 17:34","pubTimestamp":1742981658,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2360032135.SGD","LU2097344431.USD","VERX","LU0149725797.USD","LU1066051498.USD","LU2286300806.USD","IE00BJLML261.HKD","LU2461242641.AUD","LU1037948897.HKD","LU1064131342.USD","LU1093756168.USD","IE00B775SV38.USD","LU2430703178.SGD","LU0203347892.USD","LU2756315318.SGD","SG9999000418.SGD","BK4566","LU1429558221.USD","LU0477156953.USD","161631","LU0689472784.USD","LU0316494557.USD","LU2236285917.USD","LU0006306889.USD","LU0211327993.USD","GOOG","LU0640476718.USD","LU0082616367.USD","LU0792757196.USD","GOOGL","LU0130517989.USD","LU0289960550.SGD","LU0109392836.USD","LU1988902786.USD","VRTX","LU1935043536.SGD","LU1720051108.HKD","LU1989764664.SGD","LU0708994859.HKD","USJW.SI","BLZ.SI","LU1093756325.SGD","IE00BJTD4V19.USD","LU0061475181.USD","SGXZ31699556.SGD","LU2242649171.HKD","LU0444973449.USD","SG9999014880.SGD","LU1935042215.USD"],"gpt_icon":0},{"id":"2518741905","title":"福泰制药跌0.96% 股价跌破500美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2518741905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518741905?lang=zh_cn&edition=full","pubTime":"2025-03-11 21:31","pubTimestamp":1741699872,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日21时31分，福泰制药股票出现异动，股价快速跳水0.96%。截至发稿，该股报495.19美元/股，成交量2.2718万股，换手率0.01%，振幅0.33%。福泰制药股票所在的生物技术行业中，整体跌幅为0.23%。福泰制药公司简介：福泰制药是一家发现和开发用于治疗严重疾病的小分子药物的全球生物技术公司。此外，福泰正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂，以及APOL1介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311213112ab5de876&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0061475181.USD","LU0109394709.USD","LU1430594728.SGD","LU0889565916.HKD","LU0320765992.SGD","IE00BZ9MQY76.HKD","IE00BFTCPJ56.SGD","LU2362541513.USD","LU2462157665.USD","BK4567","LU1585245621.USD","LU0058720904.USD","LU1093756168.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU2456880835.USD","BK4532","IE00BJT1NW94.SGD","LU2324357040.USD","LU0234570918.USD","BK4585","LU0823416689.USD","BK4588","IE0002270589.USD","LU0079474960.USD","LU2362540622.SGD","IE0002141913.USD","BK4533","LU1035775433.USD","LU2362541273.HKD","IE00B894F039.SGD","LU0289739699.SGD","LU1093756325.SGD","VRTX","LU1069344957.HKD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","IE00B19Z3B42.SGD","BK4139","IE00B19Z9Z06.USD","IE00B2B36J28.USD","LU0256863811.USD","LU0417517546.SGD","LU2237438978.USD","LU2417539215.USD","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2518272910","title":"福泰制药涨2.40% 股价突破500美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518272910?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:02","pubTimestamp":1741618975,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时02分，福泰制药股票出现波动，股价急速上涨2.40%。截至发稿，该股报500.00美元/股，成交量36.6903万股，换手率0.14%，振幅4.00%。福泰制药股票所在的生物技术行业中，整体涨幅为0.51%。福泰制药公司简介：福泰制药是一家发现和开发用于治疗严重疾病的小分子药物的全球生物技术公司。此外，福泰正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂，以及APOL1介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230255abf31e6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJT1NW94.SGD","LU0417517546.SGD","LU2362541273.HKD","IE0009355771.USD","LU1430594728.SGD","LU0058720904.USD","LU0823416689.USD","LU0256863811.USD","LU0061475181.USD","BK4585","LU2417539215.USD","LU2462157665.USD","LU2237438978.USD","IE00B19Z3B42.SGD","BK4567","IE00B2B36J28.USD","IE00B19Z9Z06.USD","LU1069344957.HKD","LU0889565916.HKD","VRTX","IE00B19Z9P08.USD","LU2362540622.SGD","LU0109394709.USD","IE00BZ9MQY76.HKD","IE00B4R5TH58.HKD","BK4139","IE0002141913.USD","IE00B19Z3581.USD","IE00B894F039.SGD","BK4532","IE00BFTCPJ56.SGD","IE0002270589.USD","LU0079474960.USD","LU1585245621.USD","BK4588","LU2362541513.USD","IE00BJJMRZ35.SGD","LU2456880835.USD","LU1093756168.USD","LU2324357040.USD","LU0234570918.USD","LU0289739699.SGD","BK4533","LU1093756325.SGD","LU2236285917.USD","LU0320765992.SGD","LU1035775433.USD"],"gpt_icon":0},{"id":"2517458248","title":"Vertex, Inc.2024财年实现净利润-52.73百万美元，同比减少302.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517458248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517458248?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363239,"startTime":"0","endTime":"0","summary":"3月8日，Vertex, Inc.公布财报，公告显示公司2024财年净利润为-52.73百万美元，同比减少302.83%；其中营业收入为6.67亿美元，同比增加16.61%，每股基本收益为-0.34美元。从资产负债表来看，Vertex, Inc.总负债9.87亿美元，其中短期债务4.07百万美元，资产负债比为1.19，流动比率为1.00。机构评级：截至2025年3月8日，当前有11家机构对Vertex, Inc.目标价做出预测，其中目标均价为48.09美元，其中最低目标价为31.00美元，最高目标价为61.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000102a2647e7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERX","VRTX"],"gpt_icon":0},{"id":"2516422519","title":"福泰制药终止一肝病基因治疗合作！","url":"https://stock-news.laohu8.com/highlight/detail?id=2516422519","media":"谈思生物","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516422519?lang=zh_cn&edition=full","pubTime":"2025-03-02 19:01","pubTimestamp":1740913309,"startTime":"0","endTime":"0","summary":"02025.03.02本文字数：713，阅读时长大约2分钟导读：Vertex制药与Verve Therapeutics终止了为期四年的基因治疗合作，合作原计划开发针对肝脏疾病的基因编辑疗法。此次终止凸显了基因治疗领域的高风险性。近日，Vertex Pharmaceuticals和Verve Therapeutics联合宣布，终止一项持续了四年的基因治疗合作。值得注意的是，Verve的主要候选药物VERVE-102正是一款针对肝脏的基因编辑疗法。这种遗传性疾病会增加患者中风和心脏病发作的风险。尽管Verve与Vertex的合作告一段落，但这并未阻碍其与其他大型制药企业的合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302191833abe4671f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0079474960.USD","LU1069344957.HKD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4532","IE00B19Z3581.USD","LU0256863811.USD","BK4585","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU2362541273.HKD","LU0234570918.USD","LU2362540622.SGD","IE00B2B36J28.USD","LU2237438978.USD","LU1093756325.SGD","BK4588","IE00B19Z3B42.SGD","BK4533","LU0889565916.HKD","LU2236285917.USD","LU0058720904.USD","IE0002270589.USD","LU1585245621.USD","LU0289739699.SGD","IE00B19Z9P08.USD","BK4139","LU0823416689.USD","LU1035775433.USD","LU1430594728.SGD","LU2462157665.USD","LU1093756168.USD","VRTX","IE00B4R5TH58.HKD","IE00B19Z9Z06.USD","BK4567","IE00BFTCPJ56.SGD","LU2362541513.USD","LU2456880835.USD","IE00BJT1NW94.SGD","LU2417539215.USD","IE0009355771.USD","LU2324357040.USD","LU0061475181.USD","IE0002141913.USD","LU0417517546.SGD"],"gpt_icon":0},{"id":"2516561294","title":"退货！福泰制药终止肝病基因疗法合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2516561294","media":"药事纵横","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516561294?lang=zh_cn&edition=full","pubTime":"2025-03-02 06:03","pubTimestamp":1740866606,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals于2025年2月27日宣布终止与Verve Therapeutics的肝病基因编辑合作，将项目权利归还给Verve。该合作始于2022年，原计划开发针对未公开肝病的体内基因编辑疗法，Vertex支付了2500万美元首付款及3500万美元股权投资，2024年Verve从中获得1190万美元收入。终止原因为Vertex“开发组合优先级调整”，这一决定给Verve的基因编辑管线带来更大压力。目前安全性数据良好，无严重不良事件，首批初步数据预计2025年Q2公布，最终数据将于2025年下半年发布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302060503abe37cb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009355771.USD","BK4139","LU1093756168.USD","IE00B19Z3581.USD","VRTX","LU1069344957.HKD","BK4532","IE0002270589.USD","LU2362540622.SGD","LU0320765992.SGD","LU2362541513.USD","IE00BJJMRZ35.SGD","LU0079474960.USD","BK4567","LU0058720904.USD","IE00B19Z3B42.SGD","LU0417517546.SGD","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU2462157665.USD","BK4585","LU1093756325.SGD","IE00BJT1NW94.SGD","LU0256863811.USD","IE0002141913.USD","LU0234570918.USD","LU0889565916.HKD","LU1430594728.SGD","IE00B19Z9P08.USD","LU0109394709.USD","LU1585245621.USD","BK4588","LU0823416689.USD","LU2362541273.HKD","IE00B2B36J28.USD","LU2417539215.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU2237438978.USD","BK4533","LU1035775433.USD","IE00BZ9MQY76.HKD","LU2324357040.USD","LU0061475181.USD","LU2236285917.USD","LU2456880835.USD"],"gpt_icon":0},{"id":"2516337139","title":"DA Davidson：维持Vertex(VERX.US)评级，由买入调整至买入评级, 目标价由62.00美元调整至55.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516337139","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516337139?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:21","pubTimestamp":1740759694,"startTime":"0","endTime":"0","summary":"DA Davidson：维持Vertex(VERX.US)评级，由买入调整至买入评级, 目标价由62.00美元调整至55.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01002148469137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VRTX","VERX"],"gpt_icon":0},{"id":"2514373293","title":"Baird：维持Vertex(VERX.US)评级，由优于大市调整至优于大市评级, 目标价由62.00美元调整至45.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373293","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514373293?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:13","pubTimestamp":1740755582,"startTime":"0","endTime":"0","summary":"Baird：维持Vertex(VERX.US)评级，由优于大市调整至优于大市评级, 目标价由62.00美元调整至45.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28231348467202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VRTX","VERX"],"gpt_icon":0},{"id":"2514378110","title":"Vertex, Inc.盘中异动 早盘股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514378110?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:33","pubTimestamp":1740753220,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时33分，Vertex, Inc.股票出现波动，股价急速跳水5.32%。Vertex, Inc.股票所在的软件服务行业中，整体跌幅为0.56%。Vertex, Inc.公司简介：Vertex Inc是一家提供税务技术和服务的公司。Vertex为特定行业提供基于云和内部部署的解决方案，涵盖收入、销售、消费者使用、增值和工资等各个税种。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223340abe0eb30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B2B36J28.USD","LU0109394709.USD","BK4023","BK4588","IE00B19Z3B42.SGD","LU1093756168.USD","LU2362540622.SGD","LU1585245621.USD","IE00B894F039.SGD","LU0889565916.HKD","LU2236285917.USD","VRTX","LU0061475181.USD","LU1430594728.SGD","IE0002141913.USD","LU0320765992.SGD","LU0566484027.USD","LU1559883803.SGD","LU2362541273.HKD","BK4139","IE00BFTCPJ56.SGD","BK4567","IE0002270589.USD","IE0009355771.USD","LU1069344957.HKD","VERX","IE00B19Z3581.USD","LU0079474960.USD","LU2362541513.USD","BK4532","LU2456880835.USD","IE00B19Z9P08.USD","LU2462157665.USD","LU2237438978.USD","BK4533","LU1035775433.USD","LU1093756325.SGD","LU1815336091.USD","IE00B4R5TH58.HKD","LU0058720904.USD","LU0256863811.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU0417517546.SGD","LU0757428866.USD","BK4585","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","LU0234570918.USD","IE00BZ9MQY76.HKD"],"gpt_icon":0},{"id":"2514332753","title":"Stifel：下调Vertex(VERX.US)评级，由买入调整至持有评级, 目标价由58.00美元调整至31.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332753","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514332753?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:05","pubTimestamp":1740751538,"startTime":"0","endTime":"0","summary":"Stifel：下调Vertex(VERX.US)评级，由买入调整至持有评级, 目标价由58.00美元调整至31.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28220548466909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VERX","VRTX"],"gpt_icon":0},{"id":"2514385453","title":"Vertex, Inc.盘中异动 快速下跌5.04%报40.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514385453?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:31","pubTimestamp":1740666710,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分，Vertex, Inc.股票出现波动，股价快速跳水5.04%。截至发稿，该股报40.48美元/股，成交量6.1931万股，换手率0.04%，振幅3.68%。Vertex, Inc.股票所在的软件服务行业中，整体涨幅为0.52%。其相关个股中，Urgent.Ly Inc.、迅雷、Amesite Inc.涨幅较大，Urgent.Ly Inc.、Atlasclear Holdings, Inc.、迅雷较为活跃，换手率分别为422.23%、257.65%、41.04%，振幅较大的相关个股有Urgent.Ly Inc.、Atlasclear Holdings, Inc.、Amesite Inc.，振幅分别为23.52%、14.18%、12.55%。Vertex, Inc.公司简介：Vertex Inc是一家提供税务技术和服务的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722315098951015&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJT1NW94.SGD","LU1559883803.SGD","LU1093756325.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","BK4567","LU0061475181.USD","LU0234570918.USD","IE00B19Z9Z06.USD","IE0009355771.USD","LU2362541273.HKD","LU2462157665.USD","IE00B19Z9P08.USD","BK4585","LU2362540622.SGD","BK4532","IE00BZ9MQY76.HKD","IE00B894F039.SGD","LU0256863811.USD","LU0417517546.SGD","LU2237438978.USD","BK4023","LU0058720904.USD","IE00B2B36J28.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","BK4139","LU0823416689.USD","LU0889565916.HKD","LU0320765992.SGD","LU1430594728.SGD","LU1035775433.USD","VERX","IE00B19Z3581.USD","LU2456880835.USD","LU2236285917.USD","LU0079474960.USD","IE0002270589.USD","LU0757428866.USD","LU0566484027.USD","IE00B19Z3B42.SGD","LU1585245621.USD","VRTX","BK4533","LU2417539215.USD","LU0289739699.SGD","BK4588","LU2362541513.USD"],"gpt_icon":0},{"id":"1180075376","title":"Vertex 2024年第四季度调整后每股收益0.15美元，超出0.14美元预期，销售额178.46百万美元亦超出176.90百万美元预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1180075376","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180075376?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:13","pubTimestamp":1740658381,"startTime":"0","endTime":"0","summary":"Vertex报告其季度每股收益为0.15美元，超出分析师普遍预期的0.14美元7.14%。这比去年同期的每股收益0.13美元增加了15.38%。以上内容来自Benzinga Earnings专栏，原文如下：Vertex  reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.14 by 7.14 percent. This is a 15.38 percent increase over earnings of $0.13 per share from the same period last year.  The company reported quarterly sales of $178.46 million which beat the analyst consensus estimate of $176.90 million by 0.88 percent.  This is a 15.20 percent increase over sa","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTNR","VERX","VRTX"],"gpt_icon":0},{"id":"2514063368","title":"Vertex(VERX.US)：2024年Q4财报实现营收1.785亿美元，前值为1.549亿美元，预期值为1.769亿美元；每股收益为0.15美元，前值为0.13美元，预期值为0.14美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514063368","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514063368?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:11","pubTimestamp":1740658319,"startTime":"0","endTime":"0","summary":"Vertex(VERX.US)：2024年Q4财报实现营收1.785亿美元，前值为1.549亿美元，预期值为1.769亿美元；每股收益为0.15美元，前值为0.13美元，预期值为0.14美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27201148436314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VERX","VRTX"],"gpt_icon":0},{"id":"2514570777","title":"【Anthropic：发布Claude 3.7 Sonnet与Claude代码】Anthropic：发布Claude 3.7 Sonnet与Claude代码。Claude 3.7 Sonnet现在可在所有CLAUDE计划、Anthropic API、亚马逊Bedrock和谷歌云的Vertex AI上使用，其扩展思维模式现已在除免费CLAUDE等级外的所有平台上线。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514570777","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514570777?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:49","pubTimestamp":1740422955,"startTime":"0","endTime":"0","summary":"Anthropic：发布Claude 3.7 Sonnet与Claude代码。Claude 3.7 Sonnet现在可在所有CLAUDE计划、Anthropic API、亚马逊Bedrock和谷歌云的Vertex AI上使用，其扩展思维模式现已在除免费CLAUDE等级外的所有平台上线。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25024948358723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0149725797.USD","IE00B19Z3581.USD","LU0130517989.USD","LU1935042215.USD","LU1674673691.USD","IE0034235188.USD","SG9999002232.USD","SG9999015986.USD","IE000W1ABFV2.USD","LU0943347566.SGD","VERX","BK4596","BK4566","LU1489326972.SGD","LU2505996681.GBP","IE00BJJMRZ35.SGD","SGXZ23171101.USD","LU1116320901.HKD","IE000ITXATA3.USD","LU1153585028.USD","LU0265550946.USD","LU0444971666.USD","BK4535","BK4524","USAW.SI","LU0823421416.USD","IE0009356076.USD","LU0426417589.USD","LU2456880835.USD","LU2213496289.HKD","SG9999014914.USD","USJW.SI","LU0130103400.USD","LU1935043536.SGD","LU1934455194.USD","LU2552382132.HKD","BK4503","IE00BMPRXN33.USD","IE00B775SV38.USD","LU0106261372.USD","LU2362541513.USD","LU0096362180.USD","LU1917777945.USD","VRTX","BK4576","LU2237443622.USD","LU1691799644.USD"],"gpt_icon":0},{"id":"2514445772","title":"Anthropic表示，Claude 3.7 Sonnet现在可在所有Claude计划、Anthropic API、亚马","url":"https://stock-news.laohu8.com/highlight/detail?id=2514445772","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514445772?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:32","pubTimestamp":1740421936,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00BJJMRX11.SGD","IE0002270589.USD","IE0003U64NQ7.SGD","LU2462157665.USD","LU1670627923.USD","SG9999017495.SGD","GOOGL","LU0683600562.USD","USJW.SI","LU0345769128.USD","LU1043141123.HKD","IE00BKVL7J92.USD","VRTX","LU0029864427.USD","BK4567","LU2750360641.GBP","USAW.SI","IE00BMPRXN33.USD","LU0256863811.USD","GB00BDT5M118.USD","LU2361045086.USD","VERX","LU1839511570.USD","LU2764263039.SGD","IE00BMPRXR70.SGD","IE00BHPRN162.USD","LU0757428866.USD","OTX.SI","LU0477156797.USD","LU0528227936.USD","LU1366333091.USD","BK4535","GOOG","LU1116320737.USD","LU2089283258.USD","SGXZ99366536.SGD","LU0345768740.USD","LU1803068979.SGD","LU2065171402.SGD","LU0889566641.SGD","IE00B775H168.HKD","LU1674673691.USD","LU0096362180.USD","LU0642271901.SGD","LU2286300806.USD","AMZN","LU0061474960.USD","BK4122","BK4554","SG9999015986.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vrtx.com","stockEarnings":[{"period":"1week","weight":-0.0336},{"period":"1month","weight":0.0004},{"period":"3month","weight":0.1916},{"period":"6month","weight":0.0619},{"period":"1year","weight":0.1809},{"period":"ytd","weight":0.2006}],"compareEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":-0.033},{"period":"3month","weight":-0.0344},{"period":"6month","weight":-0.0148},{"period":"1year","weight":0.088},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vertex Pharmaceuticals Incorporated成立于1989年,是一家全球性生物技术公司。公司致力于发现、开发、生产和商业化用于专业市场严重疾病的小分子药物。公司与一些世界上最大的制药公司、领先的非盈利性疾病研究机构及许多世界上最知名的学术机构都有合作关系。公司有两款产品：KALYDECO和INCIVEK。","yearOnYearQuotes":[{"month":1,"riseRate":0.647059,"avgChangeRate":0.034332},{"month":2,"riseRate":0.441176,"avgChangeRate":-0.000038},{"month":3,"riseRate":0.441176,"avgChangeRate":-0.019628},{"month":4,"riseRate":0.588235,"avgChangeRate":0.016525},{"month":5,"riseRate":0.575758,"avgChangeRate":0.084187},{"month":6,"riseRate":0.545455,"avgChangeRate":0.029065},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.005556},{"month":8,"riseRate":0.647059,"avgChangeRate":0.051926},{"month":9,"riseRate":0.470588,"avgChangeRate":0.031033},{"month":10,"riseRate":0.529412,"avgChangeRate":-0.001666},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.021411},{"month":12,"riseRate":0.647059,"avgChangeRate":0.072354}],"exchange":"NASDAQ","name":"福泰制药","nameEN":"Vertex Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福泰制药,VRTX,福泰制药股票,福泰制药股票老虎,福泰制药股票老虎国际,福泰制药行情,福泰制药股票行情,福泰制药股价,福泰制药股市,福泰制药股票价格,福泰制药股票交易,福泰制药股票购买,福泰制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}